NWL
50
3
UNM
71
5
GOOGL
59
3
MPC
46
-6
MCK
45
3
FLS
68
3
TXT
60
2
WMT
62
3
PH
67
3
ORCL
65
2
MU
38
2
VRSK
54
-9
RF
45
4
UA
44
5
XYL
52
3
RL
76
3
MNST
47
7
IVZ
58
8
KMI
61
4
DVA
72
4
NWL
50
3
UNM
71
5
GOOGL
59
3
MPC
46
-6
MCK
45
3
FLS
68
3
TXT
60
2
WMT
62
3
PH
67
3
ORCL
65
2
MU
38
2
VRSK
54
-9
RF
45
4
UA
44
5
XYL
52
3
RL
76
3
MNST
47
7
IVZ
58
8
KMI
61
4
DVA
72
4
Financhill
Back

EyePoint Pharmaceuticals Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
50

EYPT
EyePoint Pharmaceuticals

Last Price:
8.65
Seasonality Move:
-4.78%
Sell
27

APLS
Apellis Pharmaceuticals

Last Price:
27.53
Seasonality Move:
29.59%
Sell
50
EyePoint Pharmaceuticals (EYPT) is a Sell

Is EyePoint Pharmaceuticals a Buy, Sell or Hold?

  • The current EyePoint Pharmaceuticals [EYPT] share price is $8.63. The Score for EYPT is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • EYPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $27.51. The Score for APLS is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EYPT Stock Price Chart

What is EyePoint Pharmaceuticals's stock price today?

  • The EyePoint Pharmaceuticals share price today is $8.63
    The current trend is relatively stagnant and EYPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $27.51
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing selling pressure, which indicates risk of future bearish movement.

EYPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 53.06 Buy
Chaikin Money Flow: 175844 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.04 - 8.82) Buy
Bollinger Bands (100): (8.03 - 10.31) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.72 Sell
Relative Strength Index (14 RSI): 26.39 Sell
Chaikin Money Flow: -970276 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (29.89 - 38.79) Sell
Bollinger Bands (100): (34.31 - 41.51) Sell

EYPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.18 Buy
20-day SMA: 8.46 Buy
50-day SMA: 8.6 Buy
200-day SMA: 15.81 Sell
8-day EMA: 8.33 Buy
20-day EMA: 8.4 Buy
50-day EMA: 8.79 Sell
200-day EMA: 11.92 Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.81 Sell
20-day SMA: 33.13 Sell
50-day SMA: 36.04 Sell
200-day SMA: 48.47 Sell
8-day EMA: 29.12 Sell
20-day EMA: 32.02 Sell
50-day EMA: 35.27 Sell
200-day EMA: 44.14 Sell

EyePoint Pharmaceuticals Earnings Growth & EYPT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.42 per share, and a decrease next year of $0.94 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.30 per share, and an increase next year of $1.38 per share.

EyePoint Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):